search
Documents
Determination of Average DAR of an Antibody Drug Conjugate (ADC) Mimic using a Biozen 1.8 µm SEC-2 Column
This application note serves to highlight how native MS can be used to get intact mass for non-covalently linked large molecules, including cysteine linked ADCs.
Determination of Average DAR of an Antibody Drug Conjugate (ADC) Mimic using a Biozen 1.8 µm SEC-2 Column
This application note serves to highlight how native MS can be used to get intact mass for non-covalently linked large molecules, including cysteine linked ADCs.
Document Type:
Technical Notes
Target Industries:
Brands:
Separation Modes:
Size Exclusion
Phases:
Determination of Average DAR of an Antibody Drug Conjugate (ADC) Mimic using a Biozen 1.8 µm SEC-2 Column
This application note serves to highlight how native MS can be used to get intact mass for non-covalently linked large molecules, including cysteine linked ADCs.
| Target Industries: | Biopharmaceutical Analysis, Pharmaceutical |
| Techniques: | HPLC, HPLC-SEC |
| Brands: | Biozen LC |
| Separation Modes: | Size Exclusion |
| Phases: | Biozen-SEC-2 |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide